Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24055,1831,1.28 [1.09-1.50],0.0021313096534613
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23402,562,1.64 [1.24-2.18],0.0005059977138178
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24532,615,1.52 [1.16-1.99],0.0021826081764088
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24460,543,1.67 [1.26-2.22],0.0004033708625992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lung cancer and mesothelioma,18251,156,2.38 [1.43-3.95],0.0008639266631556
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",21318,105,2.86 [1.45-5.67],0.0025610820915025
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24453,170,1.98 [1.20-3.27],0.0076502331246401
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21126,178,2.16 [1.39-3.37],0.0006422274945629
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22909,128,2.40 [1.45-3.97],0.000666998126821
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,24399,47,3.52 [1.46-8.49],0.0049845171298984
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,24259,1470,1.36 [1.14-1.63],0.0007562398107744
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,22047,1430,1.43 [1.19-1.71],0.0001325846390546
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21001,53,3.05 [1.42-6.57],0.0043708098679172
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24003,3055,1.18 [1.04-1.33],0.0091107676461977
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,24337,1105,1.36 [1.11-1.68],0.0037267046492989
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21747,799,1.44 [1.14-1.82],0.0022786130341558
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,23017,109,2.59 [1.50-4.48],0.0006355300233625
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24260,1352,1.33 [1.12-1.58],0.0013371365093885
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23974,1199,1.41 [1.16-1.71],0.0004485845681994
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24471,47,3.34 [1.58-7.05],0.0015484387757076
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19062,81,5.89 [2.91-11.91],8.016200835693306e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypotension,24538,611,1.48 [1.13-1.95],0.0044171277398068
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24125,1341,1.28 [1.07-1.54],0.0074187708522835
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,23471,30,4.05 [1.81-9.07],0.0006615809410567
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,22358,116,2.31 [1.28-4.18],0.0055352562761201
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,24220,310,1.82 [1.25-2.64],0.0018422671779848
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24223,139,2.91 [1.78-4.75],1.9186757877794104e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,24071,183,2.04 [1.29-3.21],0.0021217765936866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24220,136,2.87 [1.75-4.72],3.052706756816473e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21929,1268,1.43 [1.18-1.73],0.0003286866581967
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Any mental disorder,23948,3287,1.31 [1.16-1.48],9.979480769486466e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22161,1500,1.41 [1.18-1.68],0.0001743000807283
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Smoking dependency,24138,1375,1.36 [1.13-1.63],0.0008419801727339
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22239,1578,1.34 [1.12-1.60],0.0010789176232073
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Alzheimer disease,24626,65,2.85 [1.33-6.11],0.0072303907039233
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Bell's palsy,23137,68,2.74 [1.32-5.65],0.0065355107791607
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Epilepsy,23239,235,1.77 [1.15-2.73],0.0099928317600109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24175,1479,1.30 [1.08-1.55],0.0046634824340101
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,24290,48,4.60 [2.08-10.15],0.0001613817124388
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24626,66,2.83 [1.32-6.04],0.0072657543617811
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24515,70,0.31 [0.14-0.71],0.0054459858491339
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24604,101,2.52 [1.35-4.69],0.0035788014512731
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24533,648,1.68 [1.30-2.19],8.672211576933291e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Early onset COPD,24349,464,1.79 [1.32-2.44],0.0002098042422498
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23472,101,2.36 [1.25-4.47],0.0081103834606184
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,24463,1117,1.47 [1.21-1.80],0.0001485017371868
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural effusion,23883,537,1.82 [1.38-2.41],2.676537296025847e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24272,876,1.38 [1.10-1.73],0.0058386193246111
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumothorax,23404,58,3.43 [1.53-7.69],0.0028063829608114
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24499,75,2.78 [1.48-5.22],0.0014336349509167
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23906,45,3.11 [1.40-6.90],0.0051833399203918
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23297,136,2.29 [1.27-4.14],0.0059476620165607
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23309,2297,1.33 [1.16-1.54],8.198396210612295e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,24262,710,1.39 [1.09-1.79],0.009305054148272
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,24162,1001,1.39 [1.12-1.73],0.0028405761209963
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,24240,54,3.30 [1.41-7.70],0.0058187093615501
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24158,756,1.45 [1.14-1.84],0.0022765480060288
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,13292,109,0.32 [0.16-0.61],0.0006132496055109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24463,1340,1.31 [1.09-1.58],0.0035232525575564
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23248,125,2.63 [1.48-4.67],0.0009747855252925
